A recent Commission Implementing Regulation extends the current EU approval period for 23 active substances including glyphosate by six months to cover delays arising from the robust evaluation process.
Fact sheets for download
Questions and Answers about glyphosate
Information provided by:
In light of the published findings and recommendations of the WHO Core Assessment Group on Pesticides Expert task force on Diazinon, Glyphosate and Malathion the Glyphosate Task Force emphasizes again that glyphosate does not pose unacceptable risks to health or the environment when used according to label directions.
Glyphosate Task Force has conducted a preliminary review of the IARC monograph and identified multiple shortcomings in IARC’s assessment: IARC’s monograph does not present new research data; the information actually selected for consideration by the IARC panel represents only a subset of the vast dataset available on glyphosate; IARC selected ...
In the interests of placing IARC’s conclusions in the appropriate context, the Glyphosate task Force wishes to highlight the clarification provided by IARC that the Monograph Programme does not constitute a risk assessment evaluation.
The Environmental Protection Agency (EPA) in the United States has published the results of its Endocrine Disruptor Screening Programme (EDSP). Results of the assessment indicate that glyphosate does not have endocrine disrupting properties.
The Glyphosate Task Force is disappointed by the Sri Lankan government's decision to ban the import and use of glyphosate. The GTF believes there is no scientific evidence to support this decision and the move will deny Sri Lanka’s farmers access to a key tool pivotal to increasing farm productivity.